{
    "id": 525,
    "fullName": "MAP2K1 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type MAP2K1 indicates that no mutation has been detected within the MAP2K1 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5604,
        "geneSymbol": "MAP2K1",
        "terms": [
            "MAP2K1",
            "CFC3",
            "MAPKK1",
            "MEK1",
            "MKK1",
            "PRKMK1"
        ]
    },
    "variant": "wild-type",
    "createDate": "05/13/2014",
    "updateDate": "04/25/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6015,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, BI-847325 treatment resulted in partial response in 1% (1/69) and stable disease in 30% (21/69) of patients with advanced solid tumors, but insufficient inhibition of MEK or Aurora kinase at maximum tolerated dose (PMID: 26650227).",
            "molecularProfile": {
                "id": 22265,
                "profileName": "AURKA wild-type MAP2K1 wild-type"
            },
            "therapy": {
                "id": 1059,
                "therapyName": "BI-847325",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 4389,
                    "pubMedId": 26650227,
                    "title": "A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26650227"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 583,
            "profileName": "MAP2K1 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 22265,
            "profileName": "AURKA wild-type MAP2K1 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}